nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adult vaccination uptake strategies in low- and middle-income countries: A systematic review
|
Perroud, Janamarie M. |
|
|
40 |
36 |
p. 5313-5321 |
artikel |
2 |
Assessing knowledge of human papillomavirus among men who have sex with men (MSM) using targeted dating applications
|
Pham, Dalton |
|
|
40 |
36 |
p. 5376-5383 |
artikel |
3 |
Cost-effectiveness of rotavirus vaccination in Mozambique
|
Lourenço Guimarães, Esperança |
|
|
40 |
36 |
p. 5338-5346 |
artikel |
4 |
COVID-19 differentiated measures for unvaccinated individuals: The need for clear goals and strong justifications
|
Chuan Voo, Teck |
|
|
40 |
36 |
p. 5333-5337 |
artikel |
5 |
COVID-19 management landscape: A need for an affordable platform to manufacture safe and efficacious biotherapeutics and prophylactics for the developing countries
|
Pidiyar, Vyankatesh |
|
|
40 |
36 |
p. 5302-5312 |
artikel |
6 |
Crowdfunding narratives and the valuation of vaccines for COVID-19
|
Snyder, Jeremy |
|
|
40 |
36 |
p. 5295-5298 |
artikel |
7 |
Editorial Board/Aims and Scope
|
|
|
|
40 |
36 |
p. IFC |
artikel |
8 |
Effect of pneumococcal conjugate vaccine on prevalence of otitis media with effusion among children in Vietnam
|
Toizumi, Michiko |
|
|
40 |
36 |
p. 5366-5375 |
artikel |
9 |
Erratum to “AgBR1 and NeSt1 antisera protect mice from Aedes aegypti-borne Zika infection” [Vaccine 39(12) (2021) 1675–1679]
|
Marin-Lopez, Alejandro |
|
|
40 |
36 |
p. 5404-5405 |
artikel |
10 |
Field evaluation of typhoid conjugate vaccine in a catch-up campaign among children aged 9 months to 15 years in Sindh, Pakistan
|
Thobani, Rozina S. |
|
|
40 |
36 |
p. 5391-5398 |
artikel |
11 |
Immunogenicity and safety of an inactivated SARS-CoV-2 vaccine (Sinopharm BBIBP-CorV) coadministered with quadrivalent split-virion inactivated influenza vaccine and 23-valent pneumococcal polysaccharide vaccine in China: A multicentre, non-inferiority, open-label, randomised, controlled, phase 4 trial
|
Chen, Haiping |
|
|
40 |
36 |
p. 5322-5332 |
artikel |
12 |
Immunogenicity and safety of a SARS-CoV-2 inactivated vaccine (CoronaVac) co-administered with an inactivated quadrivalent influenza vaccine: A randomized, open-label, controlled study in healthy adults aged 18 to 59 years in China
|
Shenyu, Wang |
|
|
40 |
36 |
p. 5356-5365 |
artikel |
13 |
One-week intramuscular or intradermal pre-exposure prophylaxis with human diploid cell vaccine or Vero cell rabies vaccine, followed by simulated post-exposure prophylaxis at one year: A phase III, open-label, randomized, controlled trial to assess immunogenicity and safety
|
Quiambao, Beatriz P. |
|
|
40 |
36 |
p. 5347-5355 |
artikel |
14 |
Response to mRNA COVID-19 vaccination in three XLA patients
|
Squire, J.D. |
|
|
40 |
36 |
p. 5299-5301 |
artikel |
15 |
Should COVID-19 vaccines be mandated in schools? - an international caregiver perspective
|
Baumer-Mouradian, Shannon H. |
|
|
40 |
36 |
p. 5384-5390 |
artikel |
16 |
Utilization of gut environment-mediated control system of host immunity in the development of vaccine adjuvants
|
Liu, Zilai |
|
|
40 |
36 |
p. 5399-5403 |
artikel |